About
Adjuvant Capital is a venture Capital firm focused on improving global health by financing life science technologies for highburden public health challenges. They see opportunity in historically overlooked market segments and translate these opportunities into social and financial returns for investors. Their mission involves deploying venture Capital to ensure the accessibility of promising public health technologies. Adjuvant Capital specifically targets infectious diseases like HIV/AIDS, tuberculosis, malaria, maternal and child health, Nutrition, and reproductive health, with a focus on driving healthcare Equity in underserved markets.